Sawyer & Company’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Sawyer & Company’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-429	Closed	-$20K	–	179
2018 Q4	$20K	Hold	429	–	–	0.01%	146
2018 Q3	$24K	Hold	429	–	–	0.01%	155
2018 Q2	$22K	Hold	429	–	–	0.01%	156
2018 Q1	$21K	Hold	429	–	–	0.01%	159
2017 Q4	$22K	Buy	+429	New	+$22K	0.01%	144

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sawyer & Company's IHE Position: Q1 2019 in Review

Sawyer & Company sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2019, closing a stake of 429 shares — an estimated $20K sold.

Sawyer & Company first reported a position in IHE in Q4 2017 and held it in 5 quarters. The position peaked at $24K in Q3 2018. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2019.

Sawyer & Company reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
Sawyer & Company sold 429 iShares US Pharmaceuticals ETF shares in Q1 2019, an estimated $20K.
Sawyer & Company first reported a position in iShares US Pharmaceuticals ETF in Q4 2017 and held it in 5 quarters.
Sawyer & Company's iShares US Pharmaceuticals ETF position peaked at $24K in Q3 2018.
91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2019.

Based on Sawyer & Company's 13F filing for Q1 2019, filed 6 May 2019.